Magnesium for Depression

Verdict: Published with Warning

Across 4 PubMed studies, the evidence for Magnesium in Depression grades Tier C — weak evidence. Effective, but with safety or population caveats.

C 🟠 C Weak Evidence Published with Warning

🔬Why this grade7-layer evidence engine

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.54
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published with Warning
Confidence
79%
Broadly consistent
Evidence level
E3
Single high-quality meta-analysis

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.40
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
L2 PubMedPrimary literature
0.60
L3 MechanismPlausibility
0.65
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.542
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

Magnesium supplementation beneficially affects depression in adults with depressive disorder: a systematic review and meta-analysis of randomized clinical trials
PMID: 38213402 2023 統合分析 n = 325
Finding: Pooled across 7 RCTs (8 effect sizes), magnesium significantly reduced depression scores (SMD -0.919, 95% CI -1.443 to -0.396, p=0.001), but heterogeneity was high (I-squared=75.6%) and only 2 of 7 trials were low-risk-of-bias.
Academic Effect size: SMD -0.919 (95% CI -1.443 to -0.396), p=0.001; I-squared=75.6%
View on PubMed
Role of magnesium supplementation in the treatment of depression: A randomized clinical trial
PMID: 28654669 2017 RCT (open-label) n = 126
Finding: Largest trial to date found a clinically meaningful net PHQ-9 improvement of -6.0 points (95% CI -7.9 to -4.2, p<0.001), but it was open-label with a no-treatment (not placebo) control, so expectancy bias cannot be excluded.
🟠 Limited quality Academic Effect size: Net PHQ-9 change -6.0 points (95% CI -7.9 to -4.2), p<0.001
View on PubMed
Effect of magnesium supplementation on depression status in depressed patients with magnesium deficiency: A randomized, double-blind, placebo-controlled trial
PMID: 28241991 2017 RCT (double-blind) n = 60
Finding: The only double-blind placebo-controlled trial showed greater BDI-II reduction with magnesium (-15.65 +/- 8.9) than placebo (-10.40 +/- 7.9, p=0.02), but it was small and restricted to magnesium-deficient patients, limiting generalizability.
Effect size: BDI-II reduction 15.65 vs 10.40 (Mg vs placebo), p=0.02
View on PubMed
Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial
PMID: 19271419 2008 RCT (open-label) n = 23
Finding: Magnesium was statistically equivalent to imipramine for depression (GDS 11.4 +/- 3.8 vs 10.9 +/- 4.3, between-group p=0.27), but with only 23 patients and no placebo arm it cannot establish efficacy versus no treatment.
🟠 Limited quality Academic Effect size: GDS 11.4 vs 10.9 (Mg vs imipramine), between-group p=0.27 (equivalence)
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
NUTRIENT SUPPLEMENT source↗
L4b EU EFSA
Supportive
a cofactor of more than 300 enzymatic reactions source↗
L4c UK NHS
Cautious
You should be able to get all the magnesium you need by eating source↗
L4d TW TFDA / 衛福部
Supportive
每日食用量中鎂含量不超過600mg source↗
L4e WHO
Supportive
magnesium sulfate injections can be given to reduce the risk of eclampsia source↗
L5a NIH Office of Dietary Supplements
Supportive
Magnesium is a cofactor in more than 300 enzyme systems source↗
L5b Mayo Clinic
Cautious
Magnesium, in any form, might help with anxiety and depression, as it is necessary to make serotonin, a neurotransmitter that affects mental health and mood. While magnesium is often marketed to help with relaxation, sleep and mood, it hasn't been proven in human studies. source↗
L5c Cleveland Clinic
Cautious
Cortisol is very important for acute stress, but in times of chronic stress, it can actually worsen depression and anxiety. ... There's some evidence to suggest magnesium can be beneficial for managing anxiety and stress — though more research is needed. ... Supplements like magnesium aren't a suitable replacement for professional medical care. source↗
L5d Harvard Health
Cautious
Unless you have a diagnosed or suspected magnesium deficiency, or a condition with clear evidence of benefit such as preeclampsia or Crohn's disease, there's no compelling reason to routinely take a magnesium supplement. Many studies of the potential benefits of magnesium are quite small, and some have inconsistent results. source↗
L5e Specialty Society (condition-mapped)
Cautious
Research increasingly demonstrates that whole foods and nutrient-dense diets are likely to provide better mental health outcomes than supplementation of isolated nutrients. Dietary supplements should be considered only as adjuncts to conventional care and used cautiously, ensuring no contraindications with prescribed psychotropic medications. source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-depression-INT-magnesium-001 繁體中文版 →